— CME WEBINAR | AFTER THE RESULTS —
MDS Risk Stratification and Curative Treatment: The Expanding Role of HCT with IPSS-M
Now available On-Demand
Earn up to 1.0 CME/CE credits*
Learn from transplant and hematology/oncology experts in a discussion on the current state of HCT eligibility and when to consider HCT for patients with MDS. They highlight results from recently published studies on the International Prognostic Scoring System (IPSS) evolving to the inclusion of molecular disease markers (IPSS-M), referral patterns for HCT in MDS, and the latest consensus guidelines for the use of HCT in treating MDS. They also discuss how advances in HCT facilitate improved survival and preserve quality of life.
•Robert P. Hasserjian, MD
Professor of Pathology - Massachusetts General Hospital/ Harvard Medical School
•Andrew Brunner, MD
Assistant in Medicine, Division of Hematology/Oncology - Massachusetts General Hospital
Assistant Professor - Harvard Medical School
•Bart L. Scott, MD
Professor, Transplantation Program, Clinical Research Division - Fred Hutch Cancer Center
•Steven Devine, MD (moderator)
Chief Medical Officer - NMDP/Be The Match
Associate Scientific Director - CIBMTR-NMDP/Be The Match
This activity is jointly provided by The France Foundation and the National Marrow Donor Program (NMDP)/Be The Match.
In support of improving patient care, this activity has been planned and implemented by The France Foundation and the NMDP/Be The Match. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: The France Foundation designates this activity for 1.0 contact hours.
All other healthcare professionals completing this course will be issued a statement of participation.
For additional CME/CE information and disclosures, click here.